about
An alternative model of H ferritin promoter transactivation by c-JunCloning of the gene coding for human L apoferritinRole of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies.Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.H-ferritin-regulated microRNAs modulate gene expression in K562 cellsPlasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional ImplicationsFTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation.Caffeine Positively Modulates Ferritin Heavy Chain Expression in H460 Cells: Effects on Cell Proliferation.Stretches of alternating poly(T-dG), with the capacity to form Z-DNA, are present in human liver transcripts.Serum Calcium Increase Correlates With Worsening of Lipid Profile: An Observational Study on a Large Cohort From South ItalyBRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cellsEarly effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individualsEpithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling.H ferritin gene silencing in a human metastatic melanoma cell line: a proteomic analysis.BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.Nucleotide sequence of a mouse tRNA gene cluster.Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition.Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells.Expression of genes of ferritin subunits in human hepatoma cell lines.High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.A proteomics approach to identify changes in protein profiles in serum of Familial Adenomatous Polyposis patients.Evaluating the inappropriateness of repeated laboratory testing in a teaching hospital of South Italy.Pulsatile perfusion with intra-aortic balloon pumping ameliorates whole body response to cardiopulmonary bypass in the elderly.Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.H ferritin silencing induces protein misfolding in K562 cells: A Raman analysis.Corrigendum to 'specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation' [International Journal of Biochemistry and Cell Biology (2007) 220-226].Human haematological and epithelial tumor-derived cell lines express distinct patterns of onco-microRNAs.Biomarker discovery by plasma proteomics in familial Brugada Syndrome.A proteomics-driven assay defines specific plasma protein signatures in different stages of Ménière's disease.DJ-1 is a reliable serum biomarker for discriminating high-risk endometrial cancer.Tissue expression and serum levels of periostin during pregnancy: a new biomarker of embryo-endometrial cross talk at implantation.Bilateral cataract in a subject carrying a C to A transition in the L ferritin promoter region.Proteomics Analysis to Assess the Role of Mitochondria in BRCA1-Mediated Breast Tumorigenesis.A novel Q3034R BRCA2 germline mutation identified in a fallopian tube cancer patient.Postmenopausal women with carotid atherosclerosis: Potential role of the serum calcium levelsCommon and interchangeable elements in the promoters of genes transcribed by RNA polymerase IIILack of a role of monocytes in the inhibition by monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens of PHA-P-induced peripheral blood mononuclear cell proliferationCardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy
P50
Q24534022-8DED18B5-001D-4562-8B90-7FDF1031D407Q24631984-BDC23539-E186-40D6-968C-851D99EBE35EQ33806889-110276FB-4A1F-4528-98B4-D41F25BB9315Q34084450-7876E50E-65EB-4983-B746-59742B03ADC6Q34618389-D2529EBA-C292-418C-A0CB-F5A672FA2B7FQ35588565-9AE3B6C9-1155-4635-9746-693BF405A782Q35659498-687FA743-B602-4D4A-94B9-F434214CB2BBQ35959777-F5FD6A72-8BB7-48D8-A22F-D1996779E52EQ36140999-B1A68A27-6FB1-4C10-8E79-1825C2B31EF3Q36622999-7EACC8C8-2056-4248-8932-CCA59BAF9268Q36653559-43F4EBCC-D84F-4D50-A22F-6F1EA926AD02Q37355031-898592D9-87C6-4667-9E81-4012D75E1310Q37651059-7FFB04D3-6EFA-4ADF-BB1F-189890A99A4AQ38642842-C1CFDB83-DE4D-4161-AF17-63A03587BFDEQ39062662-E4473C2A-7ECB-46C3-9241-1514954BA6F0Q39449730-DAA2D0C6-F9D5-4D5E-98F5-640478B6BE60Q39921986-3E2CD947-5625-48CA-AE4F-3A874BE0BEDAQ40391187-D0044AE8-387E-4551-858A-C2003A7A1F85Q42036173-E401352D-4D24-4127-B5AA-5F02381F7037Q44324575-2FAFDDFE-A2A2-4C49-A905-C55FCE7CC349Q44797078-6F83D129-D0F0-4ABF-831A-69174C7F33BBQ45209265-7F416020-1CDD-4CD3-A0E9-9355A854F2DEQ45859964-0596E8BA-FAB8-4E59-B86F-4DAB66CD4332Q45903405-7AD2EA54-A160-4084-8B5D-5E52A345FE59Q46111964-497F8E6B-91EA-452F-B130-54AE497963F5Q46371383-9EB1DE1A-D416-4EEE-972F-F1E1E8DC4DF4Q46656668-E3EF6B20-84F2-443F-89C6-39159AB490FFQ48674202-FE1A0900-DC43-434F-8F3E-AAD65749B662Q50060804-0CE8933F-79F4-489C-A1D4-002B78761869Q50111281-2FC0FA13-A677-4E14-8A9A-03CB0F4546D1Q50356125-4395A209-B6E4-468C-98F5-428DE9316611Q50942815-E409158C-29E5-4041-B450-F44D9D67ECB2Q51165913-75B7753E-813B-4EDC-89A8-BD2E7C2DED7FQ51790339-24C6D70A-A72B-4AB9-9323-EFED213F3DF1Q53176675-155B56E7-B373-4D9A-B2CE-19BD3444F623Q54786138-6ED53850-05D5-421F-8DA0-A12232930226Q58055756-4F71A39C-EDA5-4983-81DA-4673B7D4B3A2Q58536909-1105FDBE-E1EB-4C0B-B2D6-34706229B5C5Q60366041-ABDDF93E-E611-4060-BE3D-D19C27A5D458Q60590415-942C1CE0-6390-47A9-A112-CB9E2FC9D847
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesco Costanzo
@ast
Francesco Costanzo
@en
Francesco Costanzo
@es
Francesco Costanzo
@nl
type
label
Francesco Costanzo
@ast
Francesco Costanzo
@en
Francesco Costanzo
@es
Francesco Costanzo
@nl
prefLabel
Francesco Costanzo
@ast
Francesco Costanzo
@en
Francesco Costanzo
@es
Francesco Costanzo
@nl
P106
P1153
55759944000
P21
P31
P496
0000-0002-3096-9416